Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.
复制标题
DOI:
10.1038/s41598-018-32353-x
复制
发表时间:
2018-09-17
影响因子:
4.6
通讯作者:
Markert JM
中科院分区:
文献类型:
--
作者:
Friedman GK;Bernstock JD;Chen D;Nan L;Moore BP;Kelly VM;Youngblood SL;Langford CP;Han X;Ring EK;Beierle EA;Gillespie GY;Markert JM
Pediatric high-grade brain tumors and adult glioblastoma are associated with significant morbidity and mortality. Oncolytic herpes simplex virus-1 (oHSV) is a promising approach to target brain tumors; oHSV G207 and M032 (encodes human interleukin-12) are currently in phase I clinical trials in children with malignant supratentorial brain tumors and adults with glioblastoma, respectively. We sought to compare the sensitivity of patient-derived pediatric malignant brain tumor and adult glioblastoma xenografts to these clinically-relevant oHSV. In so doing we found that pediatric brain tumors were more sensitive to the viruses and expressed significantly more nectin-1 (CD111) than adult glioblastoma. Pediatric embryonal and glial tumors were 74-fold and 14-fold more sensitive to M002 and 16-fold and 6-fold more sensitive to G207 than adult glioblastoma, respectively. Of note, pediatric embryonal tumors were more sensitive than glial tumors. Differences in sensitivity may be due in part to nectin-1 expression, which predicted responses to the viruses. Treatment with oHSV resulted in prolonged survival in both pediatric and adult intracranial patient-dervied tumor xenograft models. Our results suggest that pediatric brain tumors are ideal targets for oHSV and that brain tumor expression of nectin-1 may be a useful biomarker to predict patient response to oHSV.
登录
查看更多内容
DOI:
10.1038/mto.2014.10
发表时间:
2015
期刊:
Molecular therapy oncolytics
影响因子:
--
作者:
Leddon JL;Chen CY;Currier MA;Wang PY;Jung FA;Denton NL;Cripe KM;Haworth KB;Arnold MA;Gross AC;Eubank TD;Goins WF;Glorioso JC;Cohen JB;Grandi P;Hildeman DA;Cripe TP
通讯作者:
Cripe TP
影响因子:
21.3
作者:
Farassati, F;Yang, AD;Lee, PWK
通讯作者:
Lee, PWK
影响因子:
5.4
作者:
Krummenacher, C;Nicola, AV;Eisenberg, RJ
通讯作者:
Eisenberg, RJ
影响因子:
12.4
作者:
Markert, James M.;Razdan, Shantanu N.;Gillespie, G. Yancey
通讯作者:
Gillespie, G. Yancey
影响因子:
4.7
作者:
Friedman GK;Raborn J;Kelly VM;Cassady KA;Markert JM;Gillespie GY
通讯作者:
Gillespie GY